Gilead Sciences Other Long Term Liabilities (Quarterly) Analysis

Gilead Sciences, Inc. (GILD)

144.82 -2.30 (-1.56%) USD | NASDAQ | Feb 26, 09:52

View Other Long Term Liabilities (Quarterly) for GILD.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	Upgrade
Johnson & Johnson	Upgrade
Eli Lilly & Co.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Moderna, Inc.	Upgrade